These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22843889)
21. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. Wang S; Ding YB; Chen GY; Xia JG; Wu ZY World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513 [TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma. Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma. Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563 [TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Mohamed MM; Sabet S; Peng DF; Nouh MA; El-Shinawi M; El-Rifai W Oxid Med Cell Longev; 2014; 2014():787195. PubMed ID: 24790704 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability. Kang YH; Bae SI; Kim WH J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297 [TBL] [Abstract][Full Text] [Related]
26. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Bae SI; Lee HS; Kim SH; Kim WH Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181 [TBL] [Abstract][Full Text] [Related]
28. Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells. An BC; Jung NK; Park CY; Oh IJ; Choi YD; Park JI; Lee SW Mol Cells; 2016 Aug; 39(8):631-8. PubMed ID: 27484907 [TBL] [Abstract][Full Text] [Related]
29. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Jin SH; Akiyama Y; Fukamachi H; Yanagihara K; Akashi T; Yuasa Y Int J Cancer; 2008 Mar; 122(5):1040-6. PubMed ID: 17957782 [TBL] [Abstract][Full Text] [Related]
30. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma. Chen H; Zheng Z; Kim KY; Jin X; Roh MR; Jin Z Oncol Rep; 2016 Nov; 36(5):2737-2744. PubMed ID: 27600457 [TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas. Hur K; Song SH; Lee HS; Ho Kim W; Bang YJ; Yang HK Biochem Biophys Res Commun; 2003 Oct; 310(3):844-51. PubMed ID: 14550281 [TBL] [Abstract][Full Text] [Related]
32. Promoter methylation and expression of TIMP3 gene in gastric cancer. Guan Z; Zhang J; Song S; Dai D Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566 [TBL] [Abstract][Full Text] [Related]
33. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation. Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178 [TBL] [Abstract][Full Text] [Related]
34. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma. Lin Y; Zhang Y; Chen Y; Liu Z Pathol Res Pract; 2019 Nov; 215(11):152676. PubMed ID: 31610903 [TBL] [Abstract][Full Text] [Related]
35. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis. Zhou C; Hu H; Zheng Z; Chen C; Li Y; Li B; Duan S Pathol Res Pract; 2019 Jul; 215(7):152443. PubMed ID: 31085009 [TBL] [Abstract][Full Text] [Related]
36. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer. Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742 [TBL] [Abstract][Full Text] [Related]
37. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer. Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764 [TBL] [Abstract][Full Text] [Related]
38. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker. Raja UM; Gopal G; Rajkumar T Asian Pac J Cancer Prev; 2012; 13(11):5563-8. PubMed ID: 23317218 [TBL] [Abstract][Full Text] [Related]
39. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens. Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645 [TBL] [Abstract][Full Text] [Related]
40. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Kokubo K; Kobayashi H; Kim MS; Sidransky D; Watanabe M Oncogene; 2010 Jun; 29(22):3263-75. PubMed ID: 20228841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]